ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Anal canal cancer: Radiation therapy (RT) target volumes and doses used in the Radiation Therapy Oncology Group (RTOG) trial 0529[1]

Anal canal cancer: Radiation therapy (RT) target volumes and doses used in the Radiation Therapy Oncology Group (RTOG) trial 0529[1]
Clinical tumor stage Planning target volume dose to primary tumor Planning target volume dose to uninvolved regional lymph nodes (elective) Planning target volume dose to involved regional lymph nodes
T1-2, N0 50.4 Gy in 28 fractions (1.8 Gy/fraction) 42 Gy in 28 fractions (1.5 Gy/fraction)  
T3-4, N0 54 Gy in 30 fractions (1.8 Gy/fraction) 45 Gy in 30 fractions (1.5 Gy/fraction)  
Node-positive, ≤3cm 54 Gy in 30 fractions (1.8 Gy/fraction)   50.4 Gy in 30 fractions (1.68 Gy/fraction)
Node-positive, >3 cm 54 Gy in 30 fractions (1.8 Gy/fraction)   54 Gy in 30 fractions (1.8 Gy/fraction)
Reference:
  1. Kachnic LA, Winter K, Myerson RJ, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 2013; 86:27.
Graphic 138930 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟